Back to Journals » Journal of Experimental Pharmacology » Volume 14

Original Research

Non-Clinical Safety Pharmacology Evaluations of Trazpiroben (TAK-906), a Novel Dopamine D2/D3 Selective Receptor Antagonist for the Management of Gastroparesis

       
Total article views   HTML views PDF downloads Totals
6,584 Dovepress* 6,305+ 369 6,674
PubMed Central* 279 66 345
Totals 6,584 435 7,019
*Since 9 February 2022
Total mentioned Facebook Delicious Reddit Twitter Others
3 0 0 0 1 2

View citations on PubMed Central and Google Scholar